IIM
AKBA icon

INTECH Investment Management’s Akebia Therapeutics AKBA Stock Holding History

INTECH Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.8K Sell
66,065
-37,322
-36% -$51.3K ﹤0.01% 1909
2025
Q4 		$166K Buy
103,387
+1,418
+1% +$2.97K ﹤0.01% 2039
2025
Q3 		$278K Sell
101,969
-40,959
-29% -$136K ﹤0.01% 1871
2025
Q2 		$520K Buy
142,928
+15,569
+12% +$42.8K ﹤0.01% 1592
2025
Q1 		$245K Buy
127,359
+9,150
+8% +$18.7K ﹤0.01% 1987
2024
Q4 		$225K Buy
118,209
+73,143
+162% +$127K ﹤0.01% 1976
2024
Q3 		$59.5K Buy
+45,066
New +$60.2K ﹤0.01% 1966

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

INTECH Investment Management's AKBA Position: Q1 2026 in Review

INTECH Investment Management reduced its Akebia Therapeutics (AKBA) stake by 36% in Q1 2026, selling an estimated $51.3K and leaving 66,065 shares worth $91.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

INTECH Investment Management first reported a position in AKBA in Q3 2024 and has held it in 7 quarters since. The position peaked at $520K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • INTECH Investment Management held 66,065 shares of Akebia Therapeutics worth $91.8K as of Q1 2026.
  • INTECH Investment Management sold 37,322 Akebia Therapeutics shares in Q1 2026, an estimated $51.3K.
  • Akebia Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1909 holding.
  • INTECH Investment Management first reported a position in Akebia Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Akebia Therapeutics position peaked at $520K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.